Dyax and Amersham Biosciences Announce Agreement for Novel Affinity Ligands in Separations
CAMBRIDGE, Mass. & PISCATAWAY, N.J.--(BW HealthWire)--March 6, 2002--Dyax Corp. (Nasdaq: DYAX - news), a biopharmaceutical company, and Amersham Biosciences, today announced that Dyax has granted to Amersham Biosciences its first ever license to practice Dyax's proprietary phage display patents in the separations field. According to the agreement, Amersham Biosciences will receive non-exclusive rights to practice Dyax's patents to discover ligands from peptide libraries for chromatography separations. Amersham Biosciences will be able to use the technology either for customer specific needs or for more broadly applicable products within the field of biological separations.
By combining Dyax's phage display patents for application in affinity ligand discovery with Amersham Biosciences' world-class media and process development capabilities, the license agreement facilitates the development of novel products to purify biopharmaceutical therapeutic products and improves manufacturing efficiencies.
``Licensing Amersham Biosciences, a market leader in biological separations, represents an excellent opportunity for Dyax to have our discovery technology combined with Amersham Biosciences' tremendous expertise in critical functions like biopharmaceutical process validation and scale up,'' said Henry E. Blair, Chairman and CEO of Dyax Corp. ``The structure of the agreement is consistent with our primary focus on biopharmaceutical development while leveraging our phage display technology in other fields.''
``We look forward to working with Dyax to develop novel affinity-based media for chromatography separations,'' said Peter Ehrenheim, Vice President of Protein Separations for Amersham Biosciences. ``Our biopharmaceutical customers need production methods that will allow for better specificity and lower overall production costs associated with downstream processing. Affinity media will provide an important robustness at the capture step, a stage that is important to gaining overall process economy.''... |
